整合性胎盘多组学分析揭示了妊娠高血压中乱的途径和潜在的预后生物标志物
Bincy Varghese1, Sreeranjini Babu2, Aishwarya Jala3
1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Guwahati, Assam, India.
Archives of medical research
|November 20, 2023
概括
这项研究确定了新型胎盘微RNA (miRNA) 和妊娠高血压 (GH) 的代谢物标志物. 这些发现为区分GH和开发预后标志物提供了潜力.
科学领域:
- 产科和妇科 产科和妇科
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 妊娠高血压 (GH) 是一种严重的妊娠并发症,发生在20周后.
- 在GH的基础上精确的分子机制仍然不完全理解.
研究的目的:
- 确定特定疾病的胎盘微RNA (miRNA) 和代谢物标记物,以区分GH.
- 整合来自胎盘组织的多omics数据 (小RNA测序和代谢学).
主要方法:
- 病例控制研究比较了健康孕妇 (HP) 和患有GH的孕妇的胎盘组织.
- 利用下一代测序用于miRNA分析和代谢物分析的代谢学.
主要成果:
- 确定了44个下调的胎盘miRNAs,包括新型和成熟的形式.
- 综合性分析揭示了GH中受干扰的途径 (纯氨酸,谷氨,葡萄糖脂,伊诺西酸盐,β-氨酸).
- 呈现了14个基因和8个代谢物,有可能将GH与HP区分开来.
结论:
- 首次鉴定了GH中差异表达的miRNA,基因和代谢途径.
- 在改变的miRNA和代谢物之间建立了一个相互连接网络.
- 这些发现为进一步研究GH分子途径和预后标志物开发提供了基础.
更多相关视频
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
849
04:17Author Spotlight: Advancing Research Through Single Cell Sequencing and Spatial Histology in Placental Tissues
Published on: September 8, 2023
1.4K
相关概念视频
01:20Pathophysiology of Diabetes
950
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
950
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K